The potential of inhibiting glutamine uptake as a therapeutic target for multiple myeloma

被引：20
|
作者：
Giuliani, Nicola [1 ]
Chiu, Martina [2 ]
Bolzoni, Marina [1 ]
Accardi, Fabrizio [1 ]
Bianchi, Massimiliano G. [2 ]
Toscani, Denise [1 ]
Aversa, Franco [1 ]
Bussolati, Ovidio [2 ]
机构：
[1] Univ Parma, Dept Clin & Expt Med, Parma, Italy
[2] Univ Parma, Dept Biomed Biotechnol & Translat Sci, Parma, Italy
来源：
EXPERT OPINION ON THERAPEUTIC TARGETS | 2017年 / 21卷 / 03期
关键词：
Multiple myeloma; glutamine; metabolism; target therapy; ASCT2; CANCER; CELLS; METABOLISM; GROWTH; TRANSPORTERS; ADDICTION; STRESS; MTORC1;
D O I：
10.1080/14728222.2017.1279148
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：231 / 234
页数：4
相关论文
共 50 条
  • [41] The HGF/c-MET axis as a potential target to overcome survival signals and improve therapeutic efficacy in multiple myeloma
    Giannoni, Paolo
    de Totero, Daniela
    CANCER DRUG RESISTANCE, 2021, 4 (04) : 923 - 933
  • [42] Exosomal circRNA as a novel potential therapeutic target for multiple myeloma-related peripheral neuropathy
    Zhang, Yanyu
    Pisano, Michael
    Li, Nianhu
    Tan, Guoqing
    Sun, Fumou
    Cheng, Yan
    Zhang, Yanyan
    Cui, Xing
    CELLULAR SIGNALLING, 2021, 78
  • [43] Chromosome 1 instability in multiple myeloma: Aberrant gene expression, pathogenesis, and potential therapeutic target
    Luo, Saiqun
    Su, Tao
    Zhou, Xiang
    Hu, Wei-Xin
    Hu, Jingping
    FASEB JOURNAL, 2022, 36 (06)
  • [44] Functional expression of aryl hydrocarbon receptor as a potential novel therapeutic target in human multiple myeloma
    Hughes, Tiffany
    Cottini, Francesca
    Catton, Evan
    Ciarlariello, David
    Chen, Luxi
    Yang, Yiping
    Liu, Bei
    Mundy-Bosse, Bethany L.
    Benson, Don M.
    LEUKEMIA & LYMPHOMA, 2021, 62 (12) : 2968 - 2980
  • [45] Exosomal circRNA as a novel potential therapeutic target for multiple myeloma-related myocardial damage
    Runjie Sun
    Wei Liu
    Yangang Zhao
    Haoyu Chen
    Zhenzhen Wang
    Yanyu Zhang
    Xiaoqi Sun
    Xing Cui
    Cancer Cell International, 21
  • [46] EZH2 as a therapeutic target for multiple myeloma and other haematological malignancies
    Tremblay-LeMay, Rosemarie
    Rastgoo, Nasrin
    Pourabdollah, Maryam
    Chang, Hong
    BIOMARKER RESEARCH, 2018, 6
  • [47] New indication for therapeutic potential of an old well-known drug (propranolol) for multiple myeloma
    Kozanoglu, Ilknur
    Yandim, Melis Kartal
    Cincin, Zeynep Birsu
    Ozdogu, Hakan
    Cakmakoglu, Bedia
    Baran, Yusuf
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2013, 139 (02) : 327 - 335
  • [48] Amiloride, An Old Diuretic Drug, Is a Potential Therapeutic Agent for Multiple Myeloma
    Rojas, Elizabeta A.
    Antonio Corchete, Luis
    San-Segundo, Laura
    Martinez-Blanch, Juan F.
    Codoner, Francisco M.
    Paino, Teresa
    Puig, Noemi
    Garcia-Sanz, Ramon
    Victoria Mateos, Maria
    Ocio, Enrique M.
    Misiewicz-Krzeminska, Irena
    Gutierrez, Norma C.
    CLINICAL CANCER RESEARCH, 2017, 23 (21) : 6602 - 6615
  • [49] Malic enzyme 2 as a potential therapeutic drug target for cancer
    Sarfraz, Iqra
    Rasul, Azhar
    Hussain, Ghulam
    Hussain, Syed Makhdoom
    Ahmad, Matloob
    Nageen, Bushra
    Jabeen, Farhat
    Selamoglu, Zeliha
    Ali, Muhammad
    IUBMB LIFE, 2018, 70 (11) : 1076 - 1083
  • [50] Ferroptosis and its potential as a therapeutic target
    Yuan, Hanshu
    Pratte, Justin
    Giardina, Charles
    BIOCHEMICAL PHARMACOLOGY, 2021, 186
12345